Pharmaco-economic impact of mucosal healing in early Crohn’s disease: an analysis of the step-up-top-down prospective follow-up study Endpoints and outcomes of therapy
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis Extraintestinal manifestations
